|
Monday, March 19 — 8:00 AM — CC 223-224
Click on the blue numbers in parentheses to display abstracts.
Click the  button next to any title to add to Itinerary Planner...
Section G1 - Pancreas Pathology
Chaired by: Vikram Deshpande and Laura Tang
| Time | Title and Authors | Itinerary
Planner |
| 8:00 |
Histologic Grading the Extent of Residual Carcinoma Following Neoadjuvant Chemoradiation in Pancreatic Ductal Adenocarcinoma: A Predictor for Patient Outcome
(1842)
D Chatterjee, MH Katz, A Rashid, GR Varadhachary, RA Wolff, H Wang, JE Lee, PWT Pisters, J-N Vauthey, C Crane, HF Gomez, JL Abbruzzese, JB Fleming, H Wang - University of Texas M.D. Anderson Cancer Center, Houston, TX
|  Add |
| 8:15 |
Low Expression of Ribonucleotide Reductase M1 Predicts Adjuvant Gemcitabine Treatment Benefit in Patients with Resectable Pancreatic Adenocarcinoma
(1878)
H Xie, W Jiang, J Jiang, Y Wang, R Kim, X Liu - Cleveland Clinic, Cleveland; Veridex LLC, Johnson & Johnson Company, San Diego; Moffitt Cancer Center, Tampa
| Add |
| 8:30 |
MDM2 SNP-309 Promoter Polymorphism, MDM2 and p53 Expression in Pancreatic Ductal Adenocarcinoma
(1879)
X Zhou, J Rock, ME McNally, M Bloomston, W Zhao, G Lozanski, WL Frankel - Ohio State Universcity, Columbus, OH
| Add |
| 8:45 |
Cystic Mucinous Duct Lesion of the Pancreas: A Clinicopathologic Analysis of 40 Examples of a Diagnostically Challenging and Terminologically Controversial Entity
(1857)
A Krasinskas, GJ Oakley, P Bagci, K-T Jang, O Basturk, JD Cheng, LE Ducato, CE Hill, I Erbarut, V Adsay - UPMC, Pittsburgh; Emory University, Atlanta; MSKCC, New York; Piedmont Hospital, Atlanta
| Add |
| 9:00 |
Ki-67 Proliferation Index and Mitotic Rate Discordance in Pancreatic Neuroendocrine Tumors Correlates with Aggressive Histologic Features and Decreased Overall Survival
(1863)
CM McCall, C Shi, T Ellison, RH Hruban, C Wolfgang, R Schulick, M Choti, D Klimstra, O Basturk, BH Edil - The Johns Hopkins University School of Medicine, Baltimore, MD; Vanderbilt University School of Medicine, Nashville, TN; Memorial Sloan-Kettering Cancer Center, New York, NY
| Add |
| 9:15 |
Activation of cdk4/Cyclind D1 and the Associated Attenuation of Rb Function in Pancreatic Neuroendocrine Tumors (Pan-NETs)
(1872)
LH Tang, DS Klimstra - Memorial Sloan Kettering Cancer Center, New York, NY
| Add |
| 9:30 |
RECESS, EXHIBITS, POSTER SESSION I
| |
|
|
